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Background
Toxic effects of highly active antiretroviral therapy
(HAART) emerge in all organs and are well known in the
peripheral nerve system. The neurotoxic impact of the
antiretroviral agents ddI, ddC, and d4T as part of HAART
on neurocognitive function during HIV-infection was
studied.
Methods
In a retrospective cross-sectional study, parameters of
event-related potentials (ERPs) were analysed from
patients receiving HAART with ddI, ddC, d4T for at least 3
month (n = 60) with a mean intake of 24 ± 6 months (mv
± 1 SD). Results were compared to a control group receiv-
ing HAART without these substances. The latency of P2,
N2, P3 and the amplitude of P3 of ERPs and the mean
reaction time were analysed. Cognitive impairment (CI)
and distal-symmetric polyneuropathy (DSP) were investi-
gated using routine clinical and neurophysiological meth-
ods.
Summary of results
Statistical analysis revealed no significant difference for
age, sex, CDC-stages, CD4+-cell count and plasma viral
load between both groups. Patients treated with ddI, ddC
and d4T showed a significant latency prolongation of the
P3 component of ERP of 448 ± 45 vs. 431 ± 33 msec (mv
± 1 SD) (p < 0.02). Routine clinical and neurophysiologi-
cal methods revealed significant higher prevalence of CI
and DSP in the group receiving HAART with ddI, ddC or
d4T (p < 0.009).
Conclusion
In concordance with earlier publications, these results
show using clinical and neurophysiological methods that
ddI, ddC and d4T cause additionally, besides HIV infec-
tion itself, cognitive impairment in HIV-infected patients.
It is assumed that these alterations are induced by the
toxic impact of ddI, ddC, and d4T on β-polymerase in
mitochondriae of the CNS. As shown in newborns, this
effect may last up to 2 years after finishing HAART. Neu-
rotoxic effects of ddI, ddC, and d4T represent an addi-
tional factor in the development of newer forms of HIV-
associated neurocognitive disorders.
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